In vitro and in vivo aspects of quantifying intrapulmonary deposition of a dry powder radioaerosol.

Bondesson, Eva; Asking, Lars; Borgström, Lars; Nilsson, Lars-Erik; Trofast, Eva; Wollmer, Per

Bondesson, Eva; Asking, Lars; Borgström, Lars; Nilsson, Lars-Erik; Trofast, Eva; Wollmer, Per.

Affiliation

Bondesson E; Department of Clinical Physiology, Lund University, Malmö University Hospital, S-205 02, Malmö, Sweden. eva.bondesson@astrazeneca.com

Int J Pharm ; 232(1-2): 149-56, 2002 Jan 31.

Article in En | MEDLINE | ID: mdl-11790498

Subject(s)

Administration, Inhalation; Lactose/pharmacokinetics; Lung/metabolism; Adult; Analysis of Variance; Cross-Over Studies; Humans; Lactose/administration & dosage; Lung/diagnostic imaging; Male; Powders; Radionuclide Imaging; Technetium; Tissue Distribution

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Administration, Inhalation / Lactose / Lung Type of study: Clinical_trials Limits: Adult / Humans / Male Language: En Journal: Int J Pharm Year: 2002 Document type: Article Affiliation country: Sweden

Search on Google

Add to My VHL

XML

PubMed Links